Summary: The actions of TRH and its analog, y -butyrolactone -y -carbonylhistidyl prolinamide citrate (DN-1417) on the unit activities of the cerebral cortex, caudate -putamen and nucleus accumbens were examined using a microelectrophoretic technique in anesthetized rats. Over 80% of the neurons examined in the nucleus accumbens responded to TRH and DN -1417. The effects were mainly inhibitory, but excitatory effects (12-17%) were also detected. In the cerebral cortex and caudate -putamen, only one-third of the neurons were depressed by TRH and DN-1417. DN-1417 exerted an effect similar to TRH on almost all neurons. Dopamine affected almost all neurons.
Summary: The actions of TRH and its analog, y -butyrolactone -y -carbonylhistidyl prolinamide citrate (DN-1417) on the unit activities of the cerebral cortex, caudate -putamen and nucleus accumbens were examined using a microelectrophoretic technique in anesthetized rats. Over 80% of the neurons examined in the nucleus accumbens responded to TRH and DN -1417. The effects were mainly inhibitory, but excitatory effects (12-17%) were also detected. In the cerebral cortex and caudate -putamen, only one-third of the neurons were depressed by TRH and DN-1417. DN-1417 exerted an effect similar to TRH on almost all neurons. Dopamine affected almost all neurons. Its main effect was inhibition, but excitation was also observed in some neurons of the nucleus accumbens.
Methamphetamine mimicked dopamine in the three regions. However, it was observed that TRH and DN-1417 mimicked dopamine only in the nucleus accumbens neurons.
Furthermore, both the inhibitory and excitatory actions of TRH, DN -1417 or dopamine were attenuated by the dopamine receptor antagonist, haloperidol, which was administered systemically. These results suggest that : (1) TRH and DN -1417 have similar actions on the neurons; (2) TRH and DN-1417 act more selectively than dopamine and methamphetamine on the nucleus accumbens neurons, and they may act indirectly on dopaminergic neurons of the nucleus accumbens through an action on presynaptic sites; (3) Endogenous TRH may play a physiological role as a neuromodulator of dopaminergic transmission in the nucleus accumbens.
Introduction
Thyrotropin -releasing hormone (TRH), a hypothalamic substance which regulates pituitary-thyroid function, is widely distributed in the brain (Hokfelt et al. 1975; Winokur and Utiger, 1975) . It has been shown that TRH produces may central nervous effects, such as antagonism to central depressants (Breese et al. 1975 ), potentiation of the actions of L -DOPA (Plotnikoff et al. 1972 ) and a motor stimulatory action (Goujet et al. 1975) . Also, nerve terminals containing TRH (Hokf elt et al. 1975) , high affinity TRH-binding sites (Burt and Snyder, 1975) and TRH degradation enzymes (Griffiths et al. 1976) have been found within the brain. It has been proposed that TRH may act as a neurotransmitter or neuromodulator within the central nervous system (Emson, 1979; Morley, 1979; Snyder, 1980 The effects of TRH and DN-1417 were dose-dependent and reproducible, irrespective of the number of applications.
The latency of onset of the drug effect was 2 to 20 sec. TRH and DN -1417 almost always produced the same response in individual neurons.
Effects of DA, MAP, GABA and ACh on activities i n neurons of the cerebral cortex, caudate -putamen and nucleus accumbens DA: Almost all neurons in the cerebral cortex, caudate -putamen and nucleus accumbens were affected by DA application (78, 94% and 96%, respectively). Its primary effect was suppressive (Table 1) .
In the nucleus accumbens, the excitatory effect of DA was observed more f requently (9.9%) than in the other two regions. DA produced a dose-dependent effect with an onset latency of 2 to 5 sec (Fig. 1) .
The effects of TRH, DN -1417 and MAP on DA-responsive neurons were studied (Fig. 2) . It was noted that TRH and DN -1417 had similar actions on the DA response in most of the nucleus accumbens neurons, which responded to DA by either inhibition or excitation. TRH and DN-1417 had smaller inhibitory effects in cortical Number of neurons affected by TRH, DN-1417, dopamine, methamphetamine (MAP), acetylcholine (ACh) and GABA Fig. 1 . Dose -dependent effects of electrophoretically applied dopamine (DA), TRH and DN-1417 (DN) on the firing rate of a neuron in the nucleus accumbens.
The neuron was driven by the continuous electrophoretic application of glutamic acid (5 nA). The actions of TRH and DN were similar to the actions of DA. and caudate-putamen neurons which responded to DA than in the nucleus accumbens. MAP produced an effect similar to DA in all three brain regions. MAP: The effect of MAP on neurons in the cortex, caudate-putamen and nucleus accumbens was predominantly suppressive (73, 81% and 73%, respectively).
Only one of the 45 cells in the cortex and none of 42 cells in the caudate-putamen, gave an excitatory response to MAP.
In the nucleus accumbens, MAP induced an excitatory response more frequently (15%) than in the other two regions ( Table 1 ). The latency of onset for the drug effect was 2 to 5 sec. GABA: All neurons were suppressed by GABA and the effect was dose-dependent. The latency of onset for GABA was shorter than for the other drugs. A postinhibitory excitation, after teh GABA application, was frequently observed. ACh: As shown in Table 1 , ACh induced excitatory effects on more than 70% of the neurons in the cerebral cortex, caudate-putamen and nucleus accumbens. Inhibitory effects were also seen in the cerebral cortex (18.4%), caudate-putamen (6.1%) and nucleus accumbens (18.7%). The effects of ACh were dose-dependent, and the onset latency for ACh was 2 to 5 sec. A rebound inhibition after a pronounced excitation was observed in some neurons.
Effect of haloperidol on the effects of TRH, DN-1417 and DA in the nucleus accumbens Haloperidol, ip, slightly increased the spontaneous firing rate of the nucleus accumbens neurons in which DA had an inhibitory action (Fig. 3) , and it decreased the spontaneous rate if DA had an excitatory effect. The effect of haloperidol pretreatment was studied on the neurons which responded to DA, TRH and DN-1417 with either inhibition or excitation. The inhibitory action of DA, TRH and DN-1417 were markedly attenuated by pretreatment with haloperidol. The excitatory effects of DA, TRH and DN-1417 were also attenuated by haloperidol (Fig. 3) . Fig. 3 . Effect of haloperidol (HAL; 2 and 1 mg/kg, ip) on the inhibitory and excitatory actions of electrophoretically applied TRH, dopamine (DA) and DN-1417 (DN). The neuron was driven by the continuous application of glutamic acid (15 nA). After the HAL injection, the inhibitory and excitatory actions of TRH, DA and DN were almost completely blocked.
Discussion
Microelectrophoretic applications of TRH and DN-1417 affected a large proportion (85-89 %) of neurons in the nucleus accumbens, but only a small proportion (less than 40%) of neurons in the cerebral cortex and caudate-putamen.
DA affected almost all neurons in these regions (78-96 %). There are several reports on the effects of TRH on cortical neurons which describe suppressive effects (Morley, 1979; Renaud and Martin, 1975) , no obvious effects (Winokur and Beckman, 1978; Yarbrough, 1976) and either excitatory or inhibitory effects (Braitman et al. 1980) . TRH and DN-1417 suppressed the firing in 37 and 32% of the cortical neurons, respectively. Bunny et al. (1976) reported that DA and norepinephrine elicited an inhibitory action on neurons in layers II , ID, V and VI of the frontal cortex. Stone et al. (1975) found that DA and amphetamine had an inhibitory action on almost all cortical neurons.
TRH and DN-1417 have been reported to have a stimulatory effect on (14C) -norepinephrine release from cortical slices although they are less active than MAP (Narumi et al. 1979) . The results of the present study suggest that the effect of TRH or DN-1417 on cerebral cortical neurons is mediated via a catecholaminergic system in the brain.
Yarbrough (1976) and Braitman (1980) reported that TRH potentiated the excitatory action of ACh on cortical neurons. In other reports, no potentiating effect of TRH on ACh-responsive cortical neurons was found (Renaud and Martin, 1975) . In the present study, TRH or DN-1417 affected some ACh-sensitive and ACh-insensitive neurons in the cerebral cortex. This was also observed in the caudate-putamen and the nucleus accumbens neurons. Moreover, GABA did not act like TRH, DN-1417 and DA in regard to latency, duration and direction of the GABA effect. This was also found in the caudate -putamen and the nucleus accumbens neurons.
In caudate -putamen which is the terminus of the nigrostriatal DA system, TRH and DN -1417 affected 36 and 28.6% of the neurons mainly in an inhibitory manner. On the other hand, DA and MAP inhibited most all the neurons (92 and 81 %). TRH and DN-1417 had the same effect on caudate -putamen neurons as DA in 37 and 28% of the neurons tested, respectively. MAP produced the same effect as DA i 86% of the caudate -putamen neurons.
There are contrasting reports (Connor, 1970; Kitai et al. 1976; McLennan and York, 1967; Spencer and Havlicek, 1975) whether DA can produce an excitatory or inhibitory action on the caudateputamen neurons, but the reason for this discrepancy is unclear (Woodruff et al. 1976) .
It has been proposed that the nucleus accumbens is a functional interface between the limbic and motor systems, and that DA has a role in modulating the nucleus accumbens (Mogenson et al. 1980; Yim and Mogenson, 1982) . TRH or DN -1417 applied microelectrophoretically affected most neurons in the nucleus accumbens (85% and 89% , respectively), mainly in an inhibitory manner. However, excitatory effects were also detected with TRH and DN -1417 application in 12 and 17% of the neurons, respectively. DA also had excitatory and inhibitory effects on the nucleus accumbens neurons in the present investigation.
Both the excitatory and inhibitory effects of DA were reduced by pretreatment with haloperidol, a DA receptor antagonist. Almost all cells responding to DA also responded to TRH, DN-1417 In summary, more cells which were sensitive to TRH and DN -1417 were found in the nucleus accumbens than in the cortical and caudate-putamen.
Also, the effect of TRH and DN -1417 on the nucleus accumbens neurons is probably mediated via a dopaminergic system, which releases DA within the nucleus accumbens.
Moreover, the present study supports the hypothesis that the nucleus accumbens has a role in eliciting the locomotor stimulatory action of TRH and DN-1417. Since it has been proposed that the nucleus accumbens is a functional interface between the limbic and motor systems, further experiments should be undertaken to clarify the physiological role of TRH in the nucleus accumbens.
